|
BEIJING (AP) - China's drug watchdog announced Saturday it has suspended the sale of a drug used to treat acute leukemia and rheumatoid arthritis in the latest move to hit the country's scandal-ridden drug industry.
The Chinese government has been trying to toughen it drug regulation amid mounting criticism — at home and aboard — that the quality of its drug, food and other products is poorly regulated.
In the past week alone, a former department head at the State Food and Drug Administration was sentenced to death on bribery charges, and it was announced that production licenses of five drug makers had been pulled over the last year and that 128 others had been penalized.
|